Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,470 | -63,778 | -50,534 | -49,732 | -39,008 |
| Depreciation Amortization | 118 | 268 | 172 | 95 | 37 |
| Accounts receivable | 79 | -79 | -79 | N/A | -5,000 |
| Accounts payable and accrued liabilities | 257 | 696 | 1,129 | 753 | 822 |
| Other Working Capital | -8,531 | 12,042 | 10,343 | 7,912 | 1,565 |
| Other Operating Activity | 6,687 | 12,016 | 13,884 | 26,983 | 33,417 |
| Operating Cash Flow | $-25,860 | $-38,835 | $-25,085 | $-13,989 | $-8,167 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -154 | -1,156 | -806 | -392 | -227 |
| Investing Cash Flow | $-154 | $-1,156 | $-806 | $-392 | $-227 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 49,309 | 84,586 | 84,510 | 84,349 | 72,117 |
| Common Stock Repurchased | 0 | -274 | -78 | -78 | -78 |
| Financing Cash Flow | $49,309 | $84,312 | $84,432 | $84,271 | $72,039 |
| Beginning Cash Position | 104,713 | 60,392 | 60,392 | 60,392 | 60,392 |
| End Cash Position | 128,008 | 104,713 | 118,933 | 130,282 | 124,037 |
| Net Cash Flow | $23,295 | $44,321 | $58,541 | $69,890 | $63,645 |
| Free Cash Flow | |||||
| Operating Cash Flow | -25,860 | -38,835 | -25,085 | -13,989 | -8,167 |
| Capital Expenditure | -154 | -1,156 | -806 | -392 | -227 |
| Free Cash Flow | -26,014 | -39,991 | -25,891 | -14,381 | -8,394 |